Application no. and date | 14155459.2 (espacenet) (Federated) (European Patent Register), 20100329 | Patent/reg. no. and date | DK/EP 2732818, 20170503 | Publication date | 20140521 | Priority no. and date | US 165447 P, 20090331, US 165419 P, 20090331 | EP pub. no. and date |
EP 2732818 20140521 | Effective date | | Applicant/owner | Ligand Pharmaceuticals Inc., 3911 Sorrento Valley Boulevard Suite 110 San Diego, CA 92121 , US | Applicant ref. no. | P4632DKEP | Inventor | Zhang, Jinkun, 11496 Tree Hollow Lane
San Diego, CA California 92128, US, Dziewanowska, Zofia E, 765 Bonair Place
La Jolla, CA California 92037, US, Belder, Rene, 579 Province Line Road
Hopewell, NJ New Jersey 08525, US, Henderson, Ian, 5220 Fiore Terrace, No. 405
San Diego, CA California 92122, US, Bogardus, Joseph B, 892 Hurricane Road
Keene, NY New York 12942, US, Zhang, Zhaoying, 20 El Dorado Way
Monroe NJ 08831, US | Representative | HØIBERG P/S, Adelgade 12, 1304 København K | Opponent | | IPC Class | A61K 31/422 (2006.01) , A61K 9/20 (2006.01) , A61P 13/12 (2006.01) , A61P 9/12 (2006.01) , C07D 413/12 (2006.01) | Title | Biphenylsulfonamidendothelin- og angiotension II-receptorantagonist til behandling af glomerulosklerose | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|